METAPLASTIC BREAST CARCINOMA
Clinical trials for METAPLASTIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METAPLASTIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METAPLASTIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail targets rare breast cancer that defies standard treatment
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—alpelisib, L-NMMA, and nab-paclitaxel—in people with a rare, aggressive form of breast cancer called metaplastic breast cancer (MpBC) that has spread or is locally advanced. The study aims to find the best dose and see if…
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Matched conditions: METAPLASTIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC